Autopsy report · NCT01492998
Role of FXR in Hepatitis C Virus Replication
Cause of deathNo reason given
Life of this trial
- Registered 8 months after it had already started.
- 15 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Hospices Civils de Lyon
- Sponsor type
- University, hospital or other
- Conditions
- Chronic Hepatitis C
- Interventions
- guggulsterone, a natural FXR antagonist.
- Participants
- 15
- Sites
- 1
- Countries
- France
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.